# Qilu Pharmaceutical Co., Ltd. (Dongjia Site) – FDA Inspection, Jun 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-dongjia-site/7ea66ec4-7eb9-4c55-a2c6-e72a1b50010e
Source feed: FDA_Inspections

> FDA inspection 1210768 of Qilu Pharmaceutical Co., Ltd. (Dongjia Site), June 16, 2023. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210768
- Company Name: Qilu Pharmaceutical Co., Ltd. (Dongjia Site)
- Inspection Date: 2023-06-16
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1239802 - 2024-05-24](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-co-ltd-dongjia-site/169ebdb8-7b4f-446a-ac03-399b804ba098)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-dongjia-site/cc92034a-0571-4e14-b26d-03e2efd1cd97

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
